tiprankstipranks
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market
PPLPHARMA
Piramal Pharma Limited
RESEARCH TOOLSreports

Piramal Pharma Limited (PPLPHARMA) Income Statement

11 Followers

Piramal Pharma Limited Income Statement

Last quarter (Q2 2026), Piramal Pharma Limited's total revenue was ₹20.44B, a decrease of -8.83% from the same quarter last year. In Q2, Piramal Pharma Limited's net income was ₹-992.20M. See Piramal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 90.61B₹ 81.06B₹ 70.32B₹ 64.72B₹ 29.00B
Gross Profit
₹ 54.89B₹ 48.48B₹ 40.32B₹ 37.91B₹ 16.46B
Operating Expenses
₹ 48.10B₹ 43.86B₹ 40.80B₹ 34.26B₹ 11.65B
Depreciation and Amortization
₹ 8.16B₹ 7.41B₹ 6.77B₹ 5.86B₹ 4.14B
EBITDA
₹ 16.49B₹ 13.67B₹ 8.94B₹ 12.60B₹ 8.94B
Operating Income
₹ 6.79B₹ 4.62B₹ -479.70M₹ 3.65B₹ 4.81B
Other Income/Expenses
₹ -2.64B₹ -2.83B₹ -721.80M₹ 1.20B₹ 2.06B
Pretax Income
₹ 4.15B₹ 1.79B₹ -1.20B₹ 4.85B₹ 6.87B
Net Income
₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Per Share Metrics
Basic EPS
₹ 0.69₹ 0.14₹ -1.54₹ 3.09₹ 4.70
Diluted EPS
₹ 0.68₹ 0.14₹ -1.54₹ 3.09₹ 4.70
Weighted Average Shares Outstanding
 1.34B 1.27B 1.21B 1.22B 1.22B
Weighted Average Shares Outstanding (Diluted)
 1.34B 1.28B 1.21B 1.22B 1.22B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History